Long‐Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study

BACKGROUND: Carvedilol may have favorable glycemic properties compared with metoprolol, but it is unknown if carvedilol has mortality benefit over metoprolol in patients with type 2 diabetes (T2D) and heart failure with reduced ejection fraction (HFrEF). METHODS AND RESULTS: Using Danish nationwide...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Brian, Pierce, Colin, Madelaire, Christian, Schou, Morten, Kristensen, Søren Lund, Gislason, Gunnar H., Køber, Lars, Torp‐Pedersen, Christian, Andersson, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649547/
https://www.ncbi.nlm.nih.gov/pubmed/34533058
http://dx.doi.org/10.1161/JAHA.121.021310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649547/
https://www.ncbi.nlm.nih.gov/pubmed/34533058
http://dx.doi.org/10.1161/JAHA.121.021310

Ejemplares similares